Restored circulating invariant NKT cells are associated with viral control in patients with chronic hepatitis B
about
Hepatitis B virus core protein interacts with CD59 to promote complement-mediated liver inflammation during chronic hepatitis B virus infectionInnate immune targets of hepatitis B virus infectionAntiviral therapy for chronic hepatitis B: Combination of nucleoside analogs and interferonViral infection parameters not nucleoside analogue itself correlates with host immunity in nucleoside analogue therapy for chronic hepatitis B.Elevated expression of LAG-3, but not PD-1, is associated with impaired iNKT cytokine production during chronic HIV-1 infection and treatment.Preserved Function of Circulating Invariant Natural Killer T Cells in Patients With Chronic Hepatitis B Virus InfectionNon-antigen-specific and antigen-specific immune therapies for chronic hepatitis B: evidences from laboratory benches and patient's bedsides.Reversal of hepatitis B virus-induced systemic immune tolerance by intrinsic innate immune stimulation.Exploring the Therapeutic Potentials of iNKT Cells for Anti-HBV Treatment.Regulation of NKT Cell Localization in Homeostasis and InfectionThe dynamic changes of circulating invariant natural killer T cells during chronic hepatitis B virus infection.Circulating CD56dim natural killer cells and CD56+ T cells that produce interferon-γ or interleukin-10 are expanded in asymptomatic, E antigen-negative patients with persistent hepatitis B virus infection.Unconventional T cells in chronic hepatitis B patients on long-term suppressive therapy with tenofovir followed by a Peg-IFN add-on strategy: A randomized study.CD1-Restricted T Cells During Persistent Virus Infections: "Sympathy for the Devil".Tim-3 blockade promotes iNKT cell function to inhibit HBV replication.
P2860
Q24336169-B81FFB7C-6AE0-4D43-B1FE-118D5ACC4419Q26743647-042C208B-E2D0-4124-A801-55B27867D8E3Q26830435-808FCC68-439E-489D-86C8-DC9A85B3701BQ33948393-D9198F46-2925-4A6C-9AEC-D31445CE3AF2Q35096435-B903B93A-3597-42A1-A662-92FB31AC9C63Q36194477-0C3035B6-ECBF-42F2-8491-89FA3BFF0EDCQ38098583-2A2EBC16-6632-4FCA-9E54-E84D57730061Q38121579-456AAD14-93B8-40D3-BF19-8351731DC7D5Q38273315-9268B90C-81B4-4D0B-A10B-D37740FA809FQ38527820-B8A6356D-14CE-4F8C-977D-61AE63DC54A8Q40774067-C034AF43-6F52-4D5A-A42B-2CBFAA144131Q41755670-2BC9E9AE-3F99-4B80-B825-9A63443903D6Q47593872-7451183A-E1B5-4B3C-AC31-33C2FF43FFBEQ52332737-C60E84FF-FBA2-4AF8-A9A2-17C41127EAF0Q54965814-E1128995-6989-42D2-9B55-3B6AEE983868
P2860
Restored circulating invariant NKT cells are associated with viral control in patients with chronic hepatitis B
description
2011 nî lūn-bûn
@nan
2011 թուականին հրատարակուած գիտական յօդուած
@hyw
2011 թվականին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Restored circulating invariant ...... ients with chronic hepatitis B
@ast
Restored circulating invariant ...... ients with chronic hepatitis B
@en
Restored circulating invariant ...... ients with chronic hepatitis B
@nl
type
label
Restored circulating invariant ...... ients with chronic hepatitis B
@ast
Restored circulating invariant ...... ients with chronic hepatitis B
@en
Restored circulating invariant ...... ients with chronic hepatitis B
@nl
prefLabel
Restored circulating invariant ...... ients with chronic hepatitis B
@ast
Restored circulating invariant ...... ients with chronic hepatitis B
@en
Restored circulating invariant ...... ients with chronic hepatitis B
@nl
P2093
P2860
P1433
P1476
Restored circulating invariant ...... ients with chronic hepatitis B
@en
P2093
Jinlin Hou
Mingxia Zhang
Qintao Lai
William G H Abbott
Xiaotao Jiang
Xuan Huang
Yongyin Li
P2860
P304
P356
10.1371/JOURNAL.PONE.0028871
P407
P577
2011-01-01T00:00:00Z